Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2015 · 10-Q
Revenue$231.83M$231.83Mno prior Q3 2014 on file Net Income$15.99M$15.99Mno prior Q3 2014 on file EPS Diluted$0.31$0.31no prior Q3 2014 on file Gross Profit$111,661,000— Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$26,893,000— Free Cash Flowderived-$2,765,000— Margins · derivedGross margin48.2%
Operating margin7.9%
Net margin6.9%
ended Dec 27, 2014 · filed Feb 5, 2015 · 40 d after period end